Executive Management

Stephen “Steve” F. Betz, Ph.D., is a Co-founder of Crinetics since its inception in 2008 and currently serves as Chief Scientific Officer. He previously served as Vice President of Biology. In addition, Steve is a board observer of Loyal (formerly known as Loyal for Dogs), a biotech company developing drugs to increase canine health span. 

Earlier in his career, he was Director of Endocrinology and Metabolism at Neurocrine Biosciences, Inc., where he worked on the discovery and development of gonadotropin-releasing hormone receptor antagonists and nonpeptide modulators of other endocrine targets. Prior to Neurocrine, he led laboratory efforts at GeneFormatics, Inc., and, from 1996 to 2000, he worked in pharmaceutical discovery at Abbott Laboratories, focusing on structure-guided drug design, assay development and compound screening in the Research Nuclear Magnetic Resonance Group.  

Steve holds a bachelor’s degree in chemistry from University of Delaware and a doctorate in chemistry from University of North Carolina at Chapel Hill.